certain identified information has been excluded from the exhibit because it is both not material and is the type that the COMPANY treats as private or confidentialSide Letter • September 14th, 2021 • MedicaMetrix, Inc/De • Surgical & medical instruments & apparatus
Contract Type FiledSeptember 14th, 2021 Company IndustryReference is hereby made to that certain Series B Preferred Stock Purchase Agreement, dated as of the date of this letter agreement (the “Purchase Agreement”), by and among MedicalMetrix, Inc. (the “Company”) and the Purchasers (as defined therein) thereunder. This letter agreement (this “Side Letter”) is being delivered in connection with the separate purchase by Janus Henderson Research Fund, (together with its (x) permitted transferees and (y) other entities under management by Janus Capital Management LLC, as defined below, the “Janus Investor”) of the Company’s Series B Preferred Stock (the “Purchased Shares”) (the Purchase Agreement, with all exhibits and schedules thereto (including without limitation the Investors’ Rights Agreement (the “Rights Agreement”), the Voting Agreement (the “Voting Agreement”) and the Right of First Refusal and Co-Sale Agreement (the “ROFR Agreement”), each as entered into pursuant to the Purchase Agreement, and as amended thereafter ), are collectivel
certain identified information has been excluded from the exhibit because it is both not material and is the type that the COMPANY treats as private or confidentialSide Letter • July 23rd, 2021 • MedicaMetrix, Inc/De • Surgical & medical instruments & apparatus
Contract Type FiledJuly 23rd, 2021 Company IndustryReference is hereby made to that certain Series B Preferred Stock Purchase Agreement, dated as of the date of this letter agreement (the “Purchase Agreement”), by and among MedicalMetrix, Inc. (the “Company”) and the Purchasers (as defined therein) thereunder. This letter agreement (this “Side Letter”) is being delivered in connection with the separate purchase by Janus Henderson Research Fund, (together with its (x) permitted transferees and (y) other entities under management by Janus Capital Management LLC, as defined below, the “Janus Investor”) of the Company’s Series B Preferred Stock (the “Purchased Shares”) (the Purchase Agreement, with all exhibits and schedules thereto (including without limitation the Investors’ Rights Agreement (the “Rights Agreement”), the Voting Agreement (the “Voting Agreement”) and the Right of First Refusal and Co-Sale Agreement (the “ROFR Agreement”), each as entered into pursuant to the Purchase Agreement, and as amended thereafter ), are collectivel